BeOne Medicines AG (STAR Market shares) (BEIGENE) income statement
SHH · Healthcare · Biotechnology · 12,000 employees · CEO John V. Oyler
- Price
- CN¥248.85 -0.16%
- Market cap
- CN¥260B
- Enterprise value
- $35.2B
- Last report
- Q2 '26 filed 2026-06-30
- Next report
- 2026-11-06
BeOne Medicines AG (STAR Market shares) (BEIGENE) reported revenue of $1.71B for Q2 '26 (+29.6% year on year), operating income of $325M (19.1% of revenue) and net income of $237M. Over the last four quarters revenue was $6.16B.
Income statement
| Income statement | Trend | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $721M | $643M | $752M | $929M | $1.05B | $1.19B | $1.12B | $1.32B | $1.41B | $1.52B | $1.52B | $1.71B | |
| Cost of revenue | $82.6M | $112M | $125M | $138M | $175M | $173M | $165M | $165M | $197M | $176M | $204M | $175M | |
| Gross profit | $638M | $531M | $627M | $791M | $872M | $1.02B | $952M | $1.15B | $1.22B | $1.34B | $1.32B | $1.53B | |
| Research & development | $426M | $484M | $461M | $454M | $534M | $561M | $482M | $525M | $524M | $605M | $523M | $612M | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $529M | $550M | $0 | $0 | |
| Other operating expenses | $4.33M | -$22.3M | $0 | $0 | $278K | $77.2M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating expenses | $796M | $866M | $888M | $898M | $989M | $1.12B | $941M | $1.06B | $1.05B | $1.16B | $1.07B | $1.21B | |
| Operating income | -$158M | -$335M | -$261M | -$107M | -$118M | -$101M | $11.1M | $87.9M | $163M | $188M | $251M | $325M | |
| Interest income | $26.6M | $16.3M | $16.2M | $13.2M | $10.6M | $7.81M | $5.85M | $3.5M | $3.03M | $20.8M | $27.8M | $27.9M | |
| Interest expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $20.9M | $33.1M | $39.7M | |
| Other non-operating income (gains on investments, FX ...) | -$44M | $46.1M | -$17.9M | -$1.24M | $27.8M | -$25.9M | -$9.8M | -$11.7M | $16M | $15.4M | -$42.5M | -$27.2M | |
| Total non-operating income | $371M | $14.8M | $17.9M | $1.24M | -$19.2M | $35.3M | $9.8M | $11.7M | -$16M | -$36.3M | $9.37M | -$12.6M | |
| Income before tax | $213M | -$320M | -$243M | -$106M | -$137M | -$65.6M | $20.9M | $99.5M | $147M | $151M | $261M | $312M | |
| Income tax | $15.2M | $14.3M | $7.72M | $14.5M | $17M | $74.1M | $19.6M | $5.23M | $22.3M | $83.9M | $32.1M | $75.5M | |
| Net income | $198M | -$335M | -$251M | -$120M | -$154M | -$140M | $1.27M | $94.3M | $125M | $67.4M | $229M | $237M | |
| EPS (basic) | $1.88 | -$3.22 | -$2.41 | -$1.15 | -$1.47 | -$1.31 | $0.01 | $6.70 | $1.13 | $0.05 | $0.16 | $0.16 | |
| EPS (diluted) | $1.88 | -$3.22 | -$2.47 | -$1.15 | -$1.47 | -$1.31 | $0.01 | $6.45 | $1.09 | $0.04 | $0.15 | $0.16 | |
| Shares (basic, weighted) | 105M | 104M | 102M | 105M | 105M | 106M | 111M | 107M | 110M | 1.44B | 1.44B | 1.45B | |
| Shares (diluted, weighted) | 105M | 104M | 104M | 105M | 105M | 106M | 111M | 109M | 115M | 1.5B | 1.51B | 1.51B | |
| Depreciation & amortization | $21.5M | $23.4M | $25.4M | $25.1M | $70.1M | $50.8M | $32.8M | $35.6M | $37.1M | $36.5M | $41M | $40.5M | |
| EBITDA | -$92.2M | -$358M | -$218M | -$80.9M | -$75.4M | -$24.3M | $53.7M | $135M | $184M | $209M | $335M | $393M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07M | $238M | $198M | $428M | $309M | $1.18B | $1.42B | $2.46B | $3.81B | $5.49B | |
| Cost of revenue | $98M | $274M | $708M | $999M | $1.37B | $165M | $286M | $380M | $594M | $808M | |
| Gross profit | -$97M | -$35.6M | -$509M | -$570M | -$1.06B | $1.01B | $1.13B | $2.08B | $3.22B | $4.68B | |
| Research & development | $98M | $269M | $679M | $927M | $1.29B | $1.46B | $1.64B | $1.78B | $1.95B | $2.13B | |
| General & administrative | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.09B | |
| Other operating expenses | -$98M | -$269M | -$678M | -$926M | -$1.29B | $750K | $0 | -$811K | -$811K | $0 | |
| Operating expenses | $20.1M | $62.9M | $196M | $390M | $601M | $2.45B | $2.92B | $3.29B | $3.78B | $4.22B | |
| Operating income | -$117M | -$98.5M | -$706M | -$960M | -$1.66B | -$1.44B | -$1.79B | -$1.21B | -$568M | $460M | |
| Interest income | $0 | $0 | $13.9M | $9.13M | $2M | $15.8M | $52.5M | $74M | $47.8M | $72.5M | |
| Interest expense | $383K | $4.11M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $59.8M | |
| Other non-operating income (gains on investments, FX ...) | $0 | $0 | $0 | $0 | $0 | -$147K | $171M | $811K | $811K | -$28.7M | |
| Total non-operating income | -$2.1M | $7.39M | $15.9M | $16.3M | $39.5M | $147K | -$171M | $382M | $35.2M | -$31.1M | |
| Income before tax | -$119M | -$91.1M | -$690M | -$944M | -$1.62B | -$1.44B | -$1.96B | -$826M | -$533M | $428M | |
| Income tax | $54K | $2.24M | -$15.8M | $6.99M | $10.4M | $19.2M | $42.8M | $55.9M | $112M | $134M | |
| Net income | -$119M | -$93.1M | -$674M | -$949M | -$1.62B | -$1.46B | -$2B | -$882M | -$645M | $295M | |
| EPS (basic) | -$3.84 | -$2.23 | -$12.15 | -$15.80 | -$19.47 | -$15.71 | -$19.43 | -$8.45 | -$6.12 | $0.21 | |
| EPS (diluted) | -$3.84 | -$2.23 | -$12.15 | -$15.80 | -$19.47 | -$15.71 | -$19.43 | -$8.45 | -$6.12 | $0.20 | |
| Shares (basic, weighted) | 31M | 41.8M | 55.4M | 60.1M | 83.5M | 92.8M | 103M | 104M | 105M | 1.42B | |
| Shares (diluted, weighted) | 31M | 41.8M | 55.4M | 60.1M | 83.5M | 92.8M | 103M | 104M | 105M | 1.47B | |
| Depreciation & amortization | $1.91M | $4.76M | $10.4M | $18.6M | $31.8M | $45.5M | $68.4M | $86.1M | $172M | $138M | |
| EBITDA | -$115M | -$93.7M | -$695M | -$941M | -$1.63B | -$1.39B | -$1.89B | -$1.12B | -$397M | $627M |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates: Financial Modeling Prep.
Data as of 2026-11-02 · Amounts in USD as reported; price and market cap in CNY.